Alexion recalls some Soliris batches

Share this article:

Pricey rare disease drug Soliris is being recalled. Manufacturer Alexion noted in an 8K that it was recalling less than 1% of its stock after tests showed visible particles in the medication. The company says replacing the drugs will cost between $10 million and $25 million, and that the recall affected only products in the US.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

The Women's Health landscape is ripe with opportunity for pharma marketers. This seven-page eBook offers product managers a guide to capitalizing on the trends, growth areas and unmet needs. Includes alternative channels to engage OB/GYNs and oncologists, and plenty of tips. Click here to access it.

Email Newsletters